Mc Guire Investment Group, LLC Recursion Pharmaceuticals, Inc. Transaction History
Mc Guire Investment Group, LLC
- $654 Million
- Q4 2024
A detailed history of Mc Guire Investment Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 23,500 shares of RXRX stock, worth $170,140. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,500Holding current value
$170,140% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
303Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$234 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$180 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$125 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$111 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.31B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...